shortagewatch

Home / Cancer and immune system / Bosutinib

ATC L01EA04 · Antineoplastic Agents

Bosutinib shortage

As of 31 Oct 2026, Bosutinib has a reported shortage in 2 of the 5 countries we track (Italy, Austria), covering 3 products.

Countries2/5
Products3packs or presentations
Short since14 Feb 202521 months ago
Earliest returnnot givencompany estimate
No return date3products
Main reasonIncreased demand
GermanyNo reported shortageItaly2 packs shortSpainNo reported shortageAustria1 pack shortBelgiumNo reported shortage

Timeline

ItalyAustria
20262027BOSUTINIB ZENTIVABOSUTINIB ZENTIVABOSUTINIB DR. REDDY’SBOSUTINIB DR. REDDY’SBosutinib Teva 100 mg Filmtabletten, 28 StücBosutinib Teva 100 mg Filmtabletten, 28 Stücktoday

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Affected products

CountryProductHolderSinceExpected backReason
ITBOSUTINIB ZENTIVAZENTIVA ITALIA S.R.L.14 Feb 2025not givenIncreased demand
Elevata richiesta/problemi produttivi
ITBOSUTINIB DR. REDDY’SDR. REDDY'S S.R.L.18 Jul 2025not givenIncreased demand
Elevata richiesta: forniture discontinue
ATBosutinib Teva 100 mg Filmtabletten, 28 Stückratiopharm Arzneimittel Vertriebs GmbH20 Jul 2026not givenDistribution or logistics
Verzögerung bei der Auslieferung

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.

Related medicines also in short supply

Dasatinib Imatinib Nilotinib